Federated Hermes’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-26
Closed -$2K 2419
2020
Q3
$2K Sell
26
-257,459
-100% -$13M ﹤0.01% 2128
2020
Q2
$9.13M Buy
257,485
+97,476
+61% +$2.85M 0.02% 566
2020
Q1
$2.16M Sell
160,009
-200,738
-56% -$3.38M 0.01% 869
2019
Q4
$7.63M Buy
+360,747
New +$6.36M 0.02% 659
2018
Q3
Sell
-93,223
Closed -$2.21M 2365
2018
Q2
$2.21M Buy
93,223
+42,288
+83% +$850K 0.01% 970
2018
Q1
$744K Buy
+50,935
New +$832K ﹤0.01% 1304
2017
Q4
Sell
-100,997
Closed -$1.41M 2261
2017
Q3
$1.41M Buy
+100,997
New +$1.01M ﹤0.01% 1078
2016
Q3
Sell
-1,668
Closed -$4K 2192
2016
Q2
$4K Buy
+1,668
New +$5.57K ﹤0.01% 1940

Federated Hermes's IMMU Position: Q4 2020 in Review

Federated Hermes sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 26 shares — an estimated $2K sold.

Federated Hermes first reported a position in IMMU in Q2 2016 and held it in 8 quarters. The position peaked at $9.13M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Federated Hermes reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Federated Hermes sold 26 Immunomedics Inc shares in Q4 2020, an estimated $2K.
  • Federated Hermes first reported a position in Immunomedics Inc in Q2 2016 and held it in 8 quarters.
  • Federated Hermes's Immunomedics Inc position peaked at $9.13M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Federated Hermes's 13F filing for Q4 2020, filed 12 Feb 2021.